drugset / Trial / NCT01428466

Japanese Phase 1 Study of GSK2585823

NCT01428466

Phase 1 Completed 20 enrolled GlaxoSmithKline
RandomizedSingle-groupSingle-blindPrevention

Summary

This is a randomized, single-center, partial-blind study to evaluate the dermal irritation potential and to detect photo-toxicity and photo-allergy potential of GSK2585823, Benzoyl peroxide BPO 5% gel, Benzoyl peroxide 3% gel, vehicle gel and negative control (distilled water) applied using Finn-Chambers® by single and 7-day repeat patch test in 20 Japanese healthy male and female volunteers. Finn-Chambers containing no investigational product will be applied in the same manner. Safety will also be assessed by measurement of vital signs, electrocardiograms, safety laboratory data and review of adverse events.

Timeline

Start
2010-11-18
Primary completion
2011-02-15
Completion
2011-02-15

Publications

  • Background Nakahara N, Nohda S, Hirama T. Dermal safety of GSK2585823 in healty Japanese subjects. [J Clin Therapeut Med]. 2012;(September):867-876.

Drugs

EvaluationDrugModalityDoseRoute
Comparator Benzoyl Peroxide Other / unclassified 3 % Topical
Comparator Benzoyl Peroxide Other / unclassified 5 % Topical
Subject Clindamycin Unknown 1 % Topical

Indications